期刊文献+

环氧合酶-2对鼻咽癌血管生成及预后的影响 被引量:16

Effect of cyclooxygenase-2 expression on angiogenesis and prognosis in nasopharyngeal carcinoma
原文传递
导出
摘要 目的 研究环氧合酶-2(COX-2)在鼻咽癌中的表达及其对血管生成及预后的影响。方法 选取临床资料完整并随访达5年以上的86例鼻咽癌患者,采用免疫组织化学技术检测活检标本中COX-2、血管内皮生长因子(VEGF)表达和微血管密度(MVD)。结果 COX-2在鼻咽癌组织中阳性表达率为73.3%(63/86),与VEGF表达[69.8%(60/86)]呈显著正相关(r_s=0.438,P<0.01),且与肿瘤分级、原发灶范围、颈淋巴结转移、远地转移及较短生存期亦具相关性。MVD平均数为32.3±12.8。结论 COX-2在鼻咽癌组织中高表达,与肿瘤血管生成密切相关,可作为预测鼻咽癌预后的一种有用指标。 Objective To assess the effect of cyclooxygenase-2 (COX-2) expression on angiogenesis and prognosis in nasopharyngeal carcinoma(NPC) . Methods The expression of COX-2, vascular endothelial growth factor (VEGF) and microvascular density (MVD) were determined with immunohistochemical method in 86 NPC patients accrued over 5 years. Results The COX-2 expression rate-73. 3 % (63/86) was positively related to VEGF expression ( r = 0.438, P < 0.01), with association with the tumor pathological grade, extent of primary lesion, lymph node metastasis, distant metastasis and shorter survival. Conclusions COX-2, being highly expressed and strongly correlated with angiogenesis in nasopharyngeal carcinoma, is apt to be used as a predictor of prognosis, including local recurrence and distant metastasis.
出处 《中华放射肿瘤学杂志》 CSCD 北大核心 2003年第3期154-157,共4页 Chinese Journal of Radiation Oncology
关键词 环氧合酶-2 鼻咽癌 血管生成 预后 免疫组织化学 Nasopharyngeal neoplasms Cyclooxygenase-2 Angiogenesis Immunohistochemistry Prognosis
  • 相关文献

参考文献13

  • 1Weidner N. Current pathologic methods for measuring intratmnoralmicrovessel density within breast carcinoma and other solid ~.Breast Cancer Res Treat, 1995,36:169-180.
  • 2Ryu HS, Chang KH, Yang HW, et al. High cyclooxygenase-2expression in stage IB cervical cancer with lymph node metastasis orparametrieal invasion. Gynecol Oncol, 2000,76:320-325.
  • 3Garcia-Rodriguez LA, Alvarez HC. Reduced risk of colorectal canceramong long-term users of aspirin and nonsteroidal antiinflammatorydrugs. Epidemiology, 2001,12:88-93.
  • 4Oshima M, Dinch~k JE, Kargman S, et al. Suppression of intestinalpolyposis in Apcb'716 knock out mice by inhibition of cydooxygenase-2(COX-2). Cell, 1996,87:803-809.
  • 5Oshima M, Murai N, Kargman S, et al. Chemoprevention of intestinalpolyposis in the Apc~'/16 mouse by rofecxib, aspecific cyclooxygenase-2inhibitor. Cancer Res, 2001,61 : 1733-1740.
  • 6l)ul~is RN, Shao J, T~ajii M, et al. GI deldy in cells overexpressingprostaglandin endoperoxide synthase-2. Cancer Res, 1996,56:733-737.
  • 7Soslow RA, Dann-enberg AJ, Rush D, et al. COX-2 is expressedinhuman pulmonary, colonic, and manmmry tumors. Cancer, 2000,89:2637-2645.
  • 8Uefuji K, Ichikura T, Mochizuki H. Expression of cyclooxygenase-2 inhmrmn gastric adenomas and adenocarcinomas. J Surg Oncol, 2001,76:26-30.
  • 9Khuri FR, Wu H, Lee JJ, et al. Cyclooxygcmase-2 overexpression is amaker of poor prognosis in stage I non-small cell lung cancer. ClinCancer Rse, 2001,7:861-899.
  • 10Zirmnermann KC, Sarbia M, Weber AA, et al. Cydooxy~2expression in human esophageal carcimm. Cancer Res, 1999,59: 198-204.

同被引文献156

引证文献16

二级引证文献48

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部